cbdMD Inc risk profile
46 Elevated one input has moved against it
Measured 1 September 2026 from YCBD's filed statements. Recomputed nightly.
46 (Elevated), driven by Cash conversion at 97, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 85 | Acute | Volatile | One-year price volatility — 195.9% |
| Operating pressure | 14 | Contained | Stable | Costs outgrowing revenue — -4.8 percentage points |
| Cash conversion | 97 | Acute | Worsening | Capital spending against operating cash — -0.13x |
| Leverage and coverage | 11 | Contained | Easing | Current ratio — 2.05x |
| Competitive position | 54 | Elevated | Stable | Revenue-growth gap against peers — -55.5 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.